Treatment planning imaging – MRI
For patients with breast cancer where a discrepancy exists between clinical assessment and conventional diagnostic imaging (mammography or tomosynthesis and ultrasound), or there is a discrepancy in conventional imaging, consider the use of magnetic resonance imaging (MRI) if the results from this imaging are expected to alter treatment planning.
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of this guidance was informed by the introduction of MBS items for MRI for this indication. The MBS items refer to ‘conventional imaging’ which has been clarified as ‘mammography or tomosynthesis and ultrasound’.
Treatment planning imaging – MRI
For patients with breast cancer where a discrepancy exists between clinical assessment and conventional diagnostic imaging (mammography or tomosynthesis and ultrasound), or there is a discrepancy in conventional imaging, consider the use of magnetic resonance imaging (MRI) if the results from this imaging are expected to alter treatment planning.
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of this guidance was informed by the introduction of MBS items for MRI for this indication. The MBS items refer to ‘conventional imaging’ which has been clarified as ‘mammography or tomosynthesis and ultrasound’.